ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2026

Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in Italy.

Ilaria Valentini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.